1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane

C65H86BBrN14O7 — CID 158102726

IUPAC1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane
SMILESCC(=O)N1c2ccc(-c3cnn(C4CC4)c3)nc2CC[C@@H]1C.CC(=O)N1c2ccc(-c3cnn(C4CC4)c3)nc2N(C(=O)CC(C)C)C[C@@H]1C.CC(=O)N1c2ccc(Br)nc2CC[C@@H]1C.CC(C)N=C=O.CC1(C)OB(c2cnn(C3CC3)c2)OC1(C)C
InChIInChI=1S/C21H27N5O2.C17H20N4O.C12H19BN2O2.C11H13BrN2O.C4H7NO/c1-13(2)9-20(28)24-11-14(3)26(15(4)27)19-8-7-18(23-21(19)24)16-10-22-25(12-16)17-5-6-17;1-11-3-6-16-17(21(11)12(2)22)8-7-15(19-16)13-9-18-20(10-13)14-4-5-14;1-11(2)12(3,4)17-13(16-11)9-7-14-15(8-9)10-5-6-10;1-7-3-4-9-10(14(7)8(2)15)5-6-11(12)13-9;1-4(2)5-3-6/h7-8,10,12-14,17H,5-6,9,11H2,1-4H3;7-11,14H,3-6H2,1-2H3;7-8,10H,5-6H2,1-4H3;5-7H,3-4H2,1-2H3;4H,1-2H3/t14-;11-;;7-;/m00.0./s1
InChIKeyFPLRYFPRWMNVGT-MKKLLJEISA-N
MW1266.21 g/mol
LogP11.16
Rot. Bonds9

About 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane

1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane (PubChem CID 158102726) has the molecular formula C65H86BBrN14O7 and a molecular weight of 1266.21 g/mol. Its IUPAC name is 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane.

Molecular Properties

Compound Name1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane
PubChem CID158102726
Molecular FormulaC65H86BBrN14O7
Molecular Weight1266.21 g/mol
Exact Mass1264.61
IUPAC Name1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane
SMILESCC(=O)N1c2ccc(-c3cnn(C4CC4)c3)nc2CC[C@@H]1C.CC(=O)N1c2ccc(-c3cnn(C4CC4)c3)nc2N(C(=O)CC(C)C)C[C@@H]1C.CC(=O)N1c2ccc(Br)nc2CC[C@@H]1C.CC(C)N=C=O.CC1(C)OB(c2cnn(C3CC3)c2)OC1(C)C
InChIInChI=1S/C21H27N5O2.C17H20N4O.C12H19BN2O2.C11H13BrN2O.C4H7NO/c1-13(2)9-20(28)24-11-14(3)26(15(4)27)19-8-7-18(23-21(19)24)16-10-22-25(12-16)17-5-6-17;1-11-3-6-16-17(21(11)12(2)22)8-7-15(19-16)13-9-18-20(10-13)14-4-5-14;1-11(2)12(3,4)17-13(16-11)9-7-14-15(8-9)10-5-6-10;1-7-3-4-9-10(14(7)8(2)15)5-6-11(12)13-9;1-4(2)5-3-6/h7-8,10,12-14,17H,5-6,9,11H2,1-4H3;7-11,14H,3-6H2,1-2H3;7-8,10H,5-6H2,1-4H3;5-7H,3-4H2,1-2H3;4H,1-2H3/t14-;11-;;7-;/m00.0./s1
InChIKeyFPLRYFPRWMNVGT-MKKLLJEISA-N
XLogP11.16
TPSA221.26 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds9
Heavy Atoms88
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001266.21
LogP ≤ 511.16
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isocyanate', 'substructure': 'N/A'}

Analyze 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane?
The IUPAC name of 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane (CID 158102726) is 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane.
What is the SMILES notation for 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane?
The canonical SMILES for 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane is CC(=O)N1c2ccc(-c3cnn(C4CC4)c3)nc2CC[C@@H]1C.CC(=O)N1c2ccc(-c3cnn(C4CC4)c3)nc2N(C(=O)CC(C)C)C[C@@H]1C.CC(=O)N1c2ccc(Br)nc2CC[C@@H]1C.CC(C)N=C=O.CC1(C)OB(c2cnn(C3CC3)c2)OC1(C)C.
What is the InChIKey of 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane?
The InChIKey is FPLRYFPRWMNVGT-MKKLLJEISA-N. The full InChI is InChI=1S/C21H27N5O2.C17H20N4O.C12H19BN2O2.C11H13BrN2O.C4H7NO/c1-13(2)9-20(28)24-11-14(3)26(15(4)27)19-8-7-18(23-21(19)24)16-10-22-25(12-16)17-5-6-17;1-11-3-6-16-17(21(11)12(2)22)8-7-15(19-16)13-9-18-20(10-13)14-4-5-14;1-11(2)12(3,4)17-13(16-11)9-7-14-15(8-9)10-5-6-10;1-7-3-4-9-10(14(7)8(2)15)5-6-11(12)13-9;1-4(2)5-3-6/h7-8,10,12-14,17H,5-6,9,11H2,1-4H3;7-11,14H,3-6H2,1-2H3;7-8,10H,5-6H2,1-4H3;5-7H,3-4H2,1-2H3;4H,1-2H3/t14-;11-;;7-;/m00.0./s1.
What are the key properties of 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane?
1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane has a molecular weight of 1266.21 g/mol, XLogP of 11.16, 9 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(2S)-1-acetyl-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-2,3-dihydropyrido[2,3-b]pyrazin-4-yl]-3-methylbutan-1-one;1-[(2S)-6-bromo-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-[(2S)-6-(1-cyclopropylpyrazol-4-yl)-2-methyl-3,4-dihydro-2H-1,5-naphthyridin-1-yl]ethanone;1-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;2-isocyanatopropane is sourced from PubChem (CID 158102726), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).